Latest From Biotech Now
At the 2013 BIO World Congress on Industrial Biotechnology in Montreal next month you’ll be able to see a Campion boat on the exhibit show floor. “What will a boat be doing on the show floor of an industrial biotech conference?” you may ask. Well, this isn’t just any boat. Two companies, Ashland and Campion, have teamed up to build better boats with bio-resins. Ashland is a specialty chemicals company that believes in the power of chemistry Read More >
As many as 49,000 people die from the flu annually, depending on the season, and children and the elderly are the most vulnerable. Among the 138 children who died from the flu during the 2012-2013 season, the Centers for Disease Control and Prevention (CDC) reports that 90 percent were not vaccinated. In addition, more than 200,000 people are hospitalized, with the most vulnerable being infants, young children, older adults, and people of all ages who Read More >
David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement.
In a speech last week at Cornell University on anti-GMO conspiracy theory, Mark Lynas told audiences “millions, possibly billions, of people have come to believe what is essentially a conspiracy theory, generating fear and misunderstanding about a whole class of technologies on an unprecedentedly global scale.” Formerly a devout anti-GMO activist himself, Lynas said his activism, “which I wrongly thought of at the time as being ‘environmental’, has done real damage in the world… I Read More >
During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC will partner with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to projects promoting innovative and collaborative research and development (R&D) between companies in Massachusetts and in the partnering regions. The program’s goal is to develop long-term collaborations to advance late-stage R&D projects in biotechnology, pharmaceuticals, medical Read More >